Cambridge Investment Research Advisors’s Calamos ETF Trust Calamos Nasdaq Equity & Income ETF CANQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Buy
80,801
+619
+0.8% +$18.7K 0.01% 1509
2026
Q1
$2.23M Sell
80,182
-2,575
-3% -$75.2K 0.01% 1510
2025
Q4
$2.46M Sell
82,757
-592
-0.7% -$17.9K 0.01% 1365
2025
Q3
$2.51M Buy
83,349
+1,369
+2% +$40.1K 0.01% 1338
2025
Q2
$2.37M Buy
81,980
+54,200
+195% +$1.47M 0.01% 1308
2025
Q1
$742K Buy
+27,780
New +$779K ﹤0.01% 2101

Other funds holding CANQ

Cambridge Investment Research Advisors's CANQ Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Calamos ETF Trust Calamos Nasdaq Equity & Income ETF (CANQ) stake by 0.77% in Q2 2026, buying an estimated $18.7K and bringing the position to 80,801 shares worth $2.47M. The position accounts for 0.01% of the portfolio, ranked #1509.

Cambridge Investment Research Advisors first reported a position in CANQ in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.51M in Q3 2025. 7 funds tracked by Wall St. Rank hold CANQ as of Q2 2026.

  • Cambridge Investment Research Advisors held 80,801 shares of Calamos ETF Trust Calamos Nasdaq Equity & Income ETF worth $2.47M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 619 Calamos ETF Trust Calamos Nasdaq Equity & Income ETF shares in Q2 2026, an estimated $18.7K.
  • Calamos ETF Trust Calamos Nasdaq Equity & Income ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1509 holding.
  • Cambridge Investment Research Advisors first reported a position in Calamos ETF Trust Calamos Nasdaq Equity & Income ETF in Q1 2025 and has held it in 6 quarters since.
  • Cambridge Investment Research Advisors's Calamos ETF Trust Calamos Nasdaq Equity & Income ETF position peaked at $2.51M in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Calamos ETF Trust Calamos Nasdaq Equity & Income ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.